Author

Claudio Borghi

Professor of Medicine-University of Bologna, Bologna-Italy - Cited by 42,539

Biography

Dr. Claudio Borghi is from Istituto Nazionale dei Tumori IRCCS, Milano, located in Italy. His study is about Clinical and Psycological Telemonitoring and Telecare of High Risk Patients with Chronic Heart Failure through Wireless Technologies: The Icaros Project. He is also specialized in Cardiovascular Pharmacology, Cardiovascular Epidemiology,  Hypertension, Cardiovascular Medicine and ACE. He published 875 articles in good journal and the articles are informative and got good citations.
Title
Cited by
Year
Post COVID-19 irritable bowel syndrome
G Marasco, C Cremon, MR Barbaro, G Cacciari, F Falangone, ...Gut 72 (3), 484-492, 2023202
15
2023
Self-reported coffee consumption and central and peripheral blood pressure in the cohort of the Brisighella Heart Study
AFG Cicero, F Fogacci, S D’Addato, E Grandi, E Rizzoli, C Borghi, ...Nutrients 1 (2), 312, 2023202
5
2023
Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences?
C Borghi, AFG Cicero, D Agnoletti, G FioriniEuropean Journal of Internal Medicine, 2023202
4
2023
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
J Tamargo, S Agewall, C Borghi, C Ceconi, E Cerbai, GA Dan, ...European Heart Journal-Cardiovascular Pharmacotherapy 9 (4), 5-70, 20220
3
2023
Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol level
P Palatini, A Virdis, S Masi, A Mengozzi, E Casiglia, V Tikhonoff, ...Nutrition, Metabolism and Cardiovascular Diseases (2), 2-0, 20220
3
2023
Capsular warning syndrome: Features, risk profile, and prognosis in a large prospective TIA cohort
M Foschi, L Pavolucci, F Rondelli, V Barone, R Rinaldi, L Spinardi, ...Cerebrovascular Diseases 5 (), 18-5, 030
2
2023
Update in uric acid, hypertension, and cardiovascular diseases
M Kuwabara, T Kodama, R Ae, M Kanbay, A Andres-Hernando, C Borghi, ...Hypertension Research, 1-13, 030
2
2023
Advances in pharmacotherapies for hyperuricemia
F Piani, D Agnoletti, C BorghiExpert Opinion on Pharmacotherapy 4 (6), 737-745, 030
2
2023
PS-BPC07-5: A REAL-WORLD ANALYSIS OF PHARMACO-UTILIZATION AND OUTCOMES OF PATIENTS ON PERINDOPRIL/AMLODIPINE/INDAPAMIDE FREE VS SINGLE-PILL COMBINATION IN ITALY
C Borghi, PB Jayagopal, A Konradi, LA Bortolotto, L Degli Esposti, ...Journal of Hypertension 4 (Suppl ), e30, 2023202
1
2023
Effectiveness of first and second‐line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management
L Gatta, OP Nyssen, G Fiorini, IM Saracino, M Pavoni, M Romano, ...United European Gastroenterology Journal (), 03-3, 2023202
1
2023
Algorithm for Mobile Platform-Based Real-Time QRS Detection
L Neri, MT Oberdier, A Augello, M Suzuki, E Tumarkin, S Jaipalli, ...Sensors 23 (3), 625, 2023202
1
2023
The short-circuit evidence on lipid-lowering drugs use in pregnancy
F Fogacci, C Borghi, AFG CiceroAtherosclerosis 368, 2-3, 2023202
1
2023
1
2023
Adherence to triple single-pill combination of perindopril/indapamide/amlodipine: findings from real-world analysis in Italy
C Borghi, PB Jayagopal, A Konradi, LA Bortolotto, L Degli Esposti, ...Advances in Therapy 40 (4), 765-772, 2023202
1
2023
Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential
AFG Cicero, F Fogacci, V Di Micoli, C Angeloni, M Giovannini, C BorghiInternational Journal of Molecular Sciences 24 (8), 7027, 2023202
1
2023
Serum uric acid and left ventricular mass index independently predict cardiovascular mortality: The uric acid right for heart health (URRAH) project
ML Muiesan, CA Rosei, A Paini, E Casiglia, M Cirillo, G Grassi, ...European Journal of Internal Medicine, 2023202
1
2023
Electrocardiogram Monitoring Wearable Devices and Artificial-Intelligence-Enabled Diagnostic Capabilities: A Review
L Neri, MT Oberdier, KCJ van Abeelen, L Menghini, E Tumarkin, ...Sensors 23 (0), 4805, 2023202
1
2023